Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Sun, Diabetes UK, Citeline News & Insights and The Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 135d ago.
Quick answers
Why is "Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Drug that delays type 1 diabetes approved for NHS The Telegraph · 135d ago
- Drug that delays onset of type 1 diabetes approved in England and Wales The Guardian · 135d ago
- Breakthrough in type 1 diabetes as drug offered on NHS delays start of disease The Sun · 135d ago
- Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHS Diabetes UK · 135d ago
- England Leads Europe In Reimbursing Sanofi’s Type 1 Diabetes Disease-Modifying Therapy Tzield Citeline News & Insights · 135d ago
- Type 1 diabetes drug will delay onset by three years The Times · 135d ago
- Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS BBC · 135d ago
Topics
Related trends
Family doctors in England to use blood tests to spot cancer early in world first
Family doctors in England prepare to deploy multi-cancer early detection blood tests in an unprecedented national rollout.
A&E warning system to flag sick children deteriorating quickly
NHS A&Es across England are rolling out a new paediatric early warning system to quickly flag deteriorating sick children.
I didn't know I was lacking in vitamin D until I collapsed at work
Increasing global reports highlight the risks of vitamin D deficiency, with cases ranging from feeling 'not right' to collapsing in the workplace.
'Ferritin face': 7 warning signs of iron deficiency you shouldn’t ignore
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Can breast cancer be treated safely without chemotherapy? 7 things we know so far about the new gene test
Recent coverage examines whether a new genetic test can safely spare breast cancer patients from chemotherapy.
NHS doctors to use AI to diagnose prostate cancer
NHS doctors are set to deploy artificial intelligence tools as a second pair of eyes to help diagnose prostate cancer.